L

Luminai

Converts SOPs into automated enterprise workflows

Senior Software Engineer - Product

Full-Time
$170k - $220k/yr
Senior
San Francisco, CA, USA+2 moreMore locations: San Mateo, CA, USA | New York, NY, USA
HybridFour days in-office per week; Wednesday is optional work-from-home.
Software EngineeringFull-Stack Engineering

About the job

Requirements
  • Proven track record of shipping high-quality code in challenging projects.
  • Significant experience working with JavaScript/TypeScript, React, and Python.
  • Experience across the entire stack, from backend to frontend.
Responsibilities
  • Lead large application development projects, including planning, designing, and implementing across the stack.
  • Collaborate and contribute to core product direction, leveraging system improvements to deliver higher customer value.
  • Maintain and enhance Luminai tooling, working on both frontend and backend components.
  • Champion software development best practices, including code reviews, testing, and maintainability, to ensure high-quality and resilient software.
  • Contribute to the design and implementation of robust API, authentication, and middleware solutions, enhancing platform scalability and security.
Desired Qualifications
  • A preference for frontend or backend work is welcome for consideration.

About the company

L

Luminai

View
cbWebsite

Luminai provides AI-powered automation for large organizations. Its platform lets enterprises upload Standard Operating Procedures (SOPs), which the system analyzes to generate automated, one-click workflows. These workflows execute tasks by simulating keyboard and mouse actions, helping ensure compliance and strong security. The product is offered on a subscription basis, with potential add-ons for custom integrations or premium support. Luminai serves sectors like healthcare, consumer, and financial services, focusing on automating manual, repetitive processes across enterprise-level operations. Its goal is to reduce operational costs and increase efficiency by eliminating the need for manual intervention in routine tasks, enabling organizations to run more work with less human input.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.4M

Headquarters

San Mateo, California

Founded

2019

Get referred to Luminai

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 Series B raised $38 million, extending runway to recruit engineers and deployment teams.
  • Health systems face staffing shortages and administrative drag, directly expanding Luminai's addressable pain point.
  • Cleveland Clinic plans eight to ten automations yearly, creating a visible expansion path in 2026.

What critics are saying

  • One Cleveland Clinic reference customer exposes concentrated revenue and reputation risk through 2027.
  • Healthcare fax-routing wins invite Epic, ServiceNow, and UiPath to bundle similar automation quickly.
  • If one critical automation fails compliance, hospital buyers freeze deployments and Luminai's workflow moat collapses.

What makes Luminai unique

  • Cleveland Clinic partnership proves Luminai handles regulated, high-volume healthcare workflows at enterprise scale.
  • Luminai combines healthcare-trained AI, human-in-the-loop validation, and customer-managed deployment options.
  • Twelve million workflow automations and 48-day time-to-value signal repeatable implementation speed.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Comprehensive healthcare benefits
  • Flexible PTO
  • Financial planning support
  • Parental leave
  • L&D stipend
  • Stipends for mental & physical wellness
  • Workstation setup, laptop included

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

-4%

2 year growth

-1%
Forbes
Apr 9th, 2026
Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations

The challenge for health systems now is finding an AI partner that can scale across use cases. That is the backdrop for Cleveland Clinic’s partnership with Luminai.

Yahoo Finance
Apr 9th, 2026
Cleveland Clinic partners with Luminai to automate healthcare workflows after $38M Series B

Cleveland Clinic has partnered with Luminai, a San Francisco-based AI startup, to automate complex administrative healthcare workflows. The collaboration coincides with Luminai's $38 million Series B funding round, bringing total capital raised to approximately $60 million, with backing from Peak XV Partners, General Catalyst, Define Ventures and Y Combinator. The health system, which employs over 80,000 staff across 23 hospitals, selected Luminai to address administrative burdens that account for roughly a quarter of US healthcare spending. Initial deployment focuses on referral management, where Cleveland Clinic processes thousands of daily faxes requiring manual review and routing. "The goal is to reduce administrative burden and allow our caregivers to focus on patient care," said Rohit Chandra, Cleveland Clinic's chief digital officer. The partnership reflects growing pressure on health systems to modernise operations whilst managing workforce shortages and rising costs.

PR Newswire
Apr 9th, 2026
Luminai raises $38M Series B to scale AI-native healthcare operations platform

Luminai, an AI-native enterprise automation platform for healthcare operations, has raised $38 million in a Series B round led by Peak XV Partners, bringing total funding to $60 million. Define Ventures joined as a new investor, with General Catalyst and Y Combinator continuing their backing. The San Francisco-based company addresses healthcare's administrative burden, which accounts for significant industry costs through fragmented systems and manual processes. Luminai's platform applies healthcare-trained AI to interpret unstructured data and coordinate end-to-end workflows across access, revenue cycle and compliance functions. Founded by Kesava Kirupa Dinakaran, the company employs talent from Palantir, Cruise, Google and Epic. The funding will expand product capabilities, grow engineering and deployment teams, and support additional enterprise customers as health systems seek scalable operational modernisation solutions.

General Catalyst
Feb 23rd, 2026
Our Investment in Luminai

We originated new companies from scratch to address the world’s unmet needs.

PR Times
Feb 13th, 2026
NYC invests in Lluminai, AI startup transforming Japan's manufacturing sector

NYC Corporation, a Tokyo-based investment firm focused on business succession and growth support for small and medium enterprises, has executed a minority investment in Luminai Corporation, a startup developing AI solutions and products for the manufacturing sector. Luminai provides AI implementation support from strategy development to system operation, and develops products that help manufacturing companies improve quality, cost and delivery through data-driven insights. The company also acquires businesses facing succession challenges and supports their transformation through technology and finance. The partnership will involve deal referrals, joint AI pilot projects using NYC's portfolio companies, back-office support for Luminai's acquired businesses, and co-investment opportunities. NYC aims to build a new ecosystem for small and medium enterprises by investing in promising startups and regional companies.